May 2016
www.fda.gov/womens
Message from the Director
It’s National Women’s Health Week (NWHW). Throughout the week, we are highlighting research and educational projects that help women make informed health choices at every stage of life from pregnancy and caregiving through menopause and healthy aging. Use the digital and print resources in this update and the resources we will be sending out via social media that you can use in your community outreach and clinical services.
After NWHW ends, continue to look to FDA for resources. I encourage you to join us in celebrating Clinical Trials Day on May 20th. Use our resources andresearch to connect with women from diverse backgrounds, ages and ethnicities on the importance of participating in clinical research. Let us continue the progress made in the inclusion of women in clinical trials by spreading the word to our networks.
Marsha Henderson, Assistant Commissioner for Women’s Health
National Women’s Health Week Resources
On May 8-14th, we celebrate National Women’s Health Week (NWHW). Throughout the week, use these tips and resources to help women take steps to protect and improve their health. Retweet and repin our images in support of NWHW.
|
FDA Workshop on the Influence of Sex on Response to Drugs and Devices
Join representatives from the FDA for a half-day workshop on May 24, 2016 at the Organization for the Study of Sex Differences Annual Meeting in Philadelphia, PA. Co-facilitated by FDA’s Office of Women’s Health and Professional Affairs and Stakeholder Engagement in the Center for Drug Evaluation and Research (CDER) under the leadership of Dr. John Whyte, the workshop will share information on the Agency’s approach to sex differences in relation to drug and device reviews and regulatory science.
|
CDER’s Deputy Center Director for Clinical Science Dr. Robert Temple will speak on Demographic Subset Differences. There will also be a presentation from the private sector regarding raising awareness of sex differences with industry leadership and evaluating sex differences in drug safety and efficacy post-approval.
FDA Authority Extended to All Tobacco Products
FDA finalized a rule extending its authority to all tobacco products, including e-cigarettes, cigars, hookah tobacco and pipe tobacco, among others. This historic rule helps implement the bipartisan Family Smoking Prevention and Tobacco Control Act of 2009 and allows the FDA to improve public health and protect future generations from the dangers of tobacco use through a variety of steps, including restricting the sale of these tobacco products to minors nationwide.
|
FDA Grand Rounds
Don't miss FDA's upcoming Grand Rounds, web cast live on Thursday, May 12 from 12-1 p.m. EDT. Dr. Patrick McDermott of FDA's Center for Veterinary Medicine will be speaking on antibiotic resistance surveillance in the age of genomics.
May is Asian American and Pacific Islander Heritage Month
Celebrate Asian American and Pacific Islander (AAPI) Heritage Month with OWH fact sheets in 13 Asian and Pacific Islander languages. Use these resources to help you connect with AAPI women on topics like heart health, osteoporosis and safe medication use.
FDA Meetings
May 24, 8:30 a.m. to 5:00 p.m.
FDA White Oak Campus, Silver Spring, MD
OWH Conference Exhibits
National Rural Health Association – May 10-13, Minneapolis, MN
American Congress of Obstetricians and Gynecologists – May 14-17, Washington, DC
American Diabetes Association Annual Clinical Conference on Diabetes – May 26-29, Jacksonville, FL
American College Health Association (ACHA) – May 31-June 4, San Francisco, CA
No hay comentarios:
Publicar un comentario